BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of xenobiotics
,
Lung cancer
,
Breast
,
Personalized medicine
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pancreas
Corpus callosum
Cerebellar vermis
Ventral tegmental area
Hippocampus
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Colon cancer LS174 cells treated with subtilase cytotoxin
Induction of pluripotency in mouse somatic cells with novel factors
Induced pluripotent stem cells induce by overexpressing E-caderin compared to conventional iPS cells
Prostate and bladder tumor, tumor-associated stromal, and normal cell expression profiling
B cell populations after immune activation
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ